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Background: Mutations in the human FOXP2 gene cause speech and language impairments. The FOXP2 protein is
a transcription factor that regulates the expression of many downstream genes, which may have important roles in
nervous system development and function. An adequate amount of functional FOXP2 protein is thought to be
critical for the proper development of the neural circuitry underlying speech and language. However, how FOXP2
gene expression is regulated is not clearly understood. The FOXP2 mRNA has an approximately 4-kb-long 3′
untranslated region (3′ UTR), twice as long as its protein coding region, indicating that FOXP2 can be regulated by
microRNAs (miRNAs).
Findings: We identified multiple miRNAs that regulate the expression of the human FOXP2 gene using sequence
analysis and in vitro cell systems. Focusing on let-7a, miR-9, and miR-129-5p, three brain-enriched miRNAs, we show
that these miRNAs regulate human FOXP2 expression in a dosage-dependent manner and target specific sequences
in the FOXP2 3′ UTR. We further show that these three miRNAs are expressed in the cerebellum of the human fetal
brain, where FOXP2 is known to be expressed.
Conclusions: Our results reveal novel regulatory functions of the human FOXP2 3′ UTR sequence and regulatory
interactions between multiple miRNAs and the human FOXP2 gene. The expression of let-7a, miR-9, and miR-129-5p
in the human fetal cerebellum is consistent with their roles in regulating FOXP2 expression during early cerebellum
development. These results suggest that various genetic and environmental factors may contribute to speech and
language development and related neural developmental disorders via the miRNA-FOXP2 regulatory network.
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Dysfunctions of the human FOXP2 gene have been impli-
cated in speech and language impairments [1-6]. As a tran-
scription factor, the FOXP2 protein controls the expression
of hundreds of downstream genes, many of which play im-
portant roles in nervous system development and function
[7-11]. An adequate amount of functional FOXP2 protein
is thought to be critical for the proper development of the
distributed neural circuits underlying speech and language
[12,13]. However, how the expression of the human FOXP2
gene is regulated is not clearly understood. miRNAs are* Correspondence: xli4@lsuhsc.edu
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unless otherwise stated.small nonprotein-coding RNA molecules that regulate
gene expression post-transcriptionally by targeting specific
sequences in the 3′-UTRs of mRNAs, leading to mRNA
degradation and/or translational suppression [14,15]. The
FOXP2 mRNA has an approximately 4-kb long 3′ UTR,
twice as long as its protein coding region [1], raising the
possibility that FOXP2 expression is regulated by miRNAs.
Here we report the identification of multiple miRNAs that
downregulate the expression of the human FOXP2 gene by
targeting specific sequences in its 3′ UTR.
Results
Identification of miRNA binding sites in the human FOXP2
3′ UTR
Using cDNAs made from human fetal brains combined
with polymerase chain reaction (PCR), we cloned aThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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human FOXP2 3′ UTR sequence annotated in the NCBI
database. We searched this FOXP2 3′ UTR sequence for
miRNA binding sites, requiring a perfect match to the
7-nt seed sequence in a miRNA [15,16]. This search
predicted numerous miRNAs that potentially target the
FOXP2 3′ UTR. Some of these miRNAs have more than
one binding site and the binding site sequences are
conserved in higher vertebrate species. We selected 12
miRNAs: miR-9, miR-19b, miR-27b, miR-92a, miR-140-5p,
miR-190, miR-200a, let-7a, miR-129-5p, miR-582-5p, miR-
892a, and miR-1237 (Figure 1) and tested whether they
downregulate FOXP2 expression in cell culture systems.
Multiple miRNAs downregulate human FOXP2 protein
and mRNA expression
We transfected mimics of each candidate miRNA into hu-
man HEK293 cells (where FOXP2 is expressed endogen-
ously) and measured FOXP2 protein levels 72 hours later
by Western blot analysis. We found that miR-9, miR-19b,
miR-140-5p, miR-200a, let-7a, miR-129-5p, miR-582-5p,
and miR-892a reduced FOXP2 protein levels significantly
(Figure 2A). Of these miRNAs, let-7a, miR-9, and miR-
129-5p were among the most effective regulators, redu-
cing FOXP2 protein by 70-90%; they are also known to be
abundantly expressed in vertebrate brains [17,18]. We fo-
cused on these three miRNAs and tested whether their
regulatory effects were dose-dependent at three dosages:
2, 6.5, and 20 nM. At 2 nM, comparing to the control, let-
7a and miR-9 each decreased FOXP2 protein levels by
about 50%, while miR-129-5p decreased FOXP2 protein
by less than 10% (p < 0.01 for all). At 20 nM, let-7a and
miR-9 decreased FOXP2 protein levels by 90%, and miR-
129-5p decreased FOXP2 protein by 70% (p < 0.001 for all,
Figure 2B and C). The dose-dependent downregulation
was significant for each miRNA (p < 0.0018 for let-7a and
miR-9; p < 0.0006 for miR-129-5p, Jonckheere-Terpstra





















Figure 1 Predicted miRNA binding sites in the human FOXP2 3′ UTR.
binding sites in the human FOXP2 3′ UTR. The first nucleotide downstreamfound that FOXP2 mRNA level was downregulated by let-
7a, miR-9, and miR-129-5p in similar transfection experi-
ments (Figure 2D).
let-7a, miR-9, and miR-129-5p target specific sequences in
the human FOXP2 3′ UTR
Next, we tested whether the regulatory effects of candi-
date miRNAs were mediated by the 3′ UTR of the hu-
man FOXP2 gene using luciferase reporter assays. We
co-transfected miRNA mimics and a luciferase reporter
construct containing a wild type FOXP2 3′ UTR or no
3′ UTR into SH-SY5Y cells, where no endogenous FOXP2
was expressed, and performed luciferase reporter assays.
Compared to a control miRNA with scrambled sequence,
the eight candidate miRNAs, miR-9, miR-19b, miR-140-
5p, miR-200a, let-7a, miR-129-5p, miR-582-5p, and
miR-892a significantly repressed luciferase activity when
co-transfected with a reporter construct containing a
wild type FOXP2 3′ UTR (p < 0.01 for all), but had no
effect when co-transfected with a reporter construct
containing no FOXP2 3′ UTR. In contrast, miR-27b,
miR-92a, miR-190, and miR-1237 did not repress lucif-
erase activity whether the reporter constructs contained
a FOXP2 3′ UTR or not (Figure 3A). These results were
consistent with the Western blot results obtained from
HEK293 cells as described in Figure 2A, indicating that
the regulatory functions of these miRNAs were inde-
pendent of the cell lines we used.
We focused on let-7a, miR-9, and miR-129-5p and fur-
ther tested whether their regulatory effects were sequence-
specific. Each of these miRNAs has two binding sites in the
human FOXP2 3′ UTR. For each miRNA, we made three
mutant luciferase reporter constructs with sequences in
binding site 1, binding site 2, and binding sites 1 + 2 mu-
tated respectively by site-directed mutagenesis (Figure 3B).
Using luciferase reporter assays, we showed that each of
these miRNAs significantly repressed luciferase activity









The numbers in the parentheses indicate the positions of miRNA
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Figure 2 Multiple miRNAs downregulate human FOXP2 expression. (A) Representative Western blot images and quantitative results
showing that miR-9, miR-19b, miR-140-5p, miR-200a, let-7a, miR-129-5p, miR-582-5p, and miR-892a downregulated human FOXP2 protein
expression when transfected into HEK293 cells. (B and C) The downregulatory effects of let-7a, miR-9, and miR-129-5p were dosage-dependent.
(D) Let-7a, miR-9, and miR-129-5p downregulated FOXP2 mRNA expression in similar transfection experiments as measured by qRT-PCR. For both
Western blot and qRT-PCR, Actin was used as an internal control; a miRNA mimic with a scrambled sequence (Ambion) was used as a negative
control; and a siRNA against FOXP2 siFOXP2 was used as a positive control. Transfection was performed at least three times (n = 3) for each
miRNA, and quantifications were averaged from the three transfections, two Western blot or two qRT-PCR experiments per transfection. *p < 0.05,
**p < 0.01, and ***p < 0.001.
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http://www.molecularbrain.com/content/7/1/71p < 0.01 for all three miRNAs), but their regulatory effects
were completely abolished when both binding sites were
mutated (p > 0.98 for all three miRNAs, Figure 3C). In
comparison, the negative control miRNA had no effect on
all reporter constructs whether it had no 3′ UTR, wildtype 3′ UTR, or mutated 3′ UTRs (Figure 3C). These re-
sults suggested that the downregulatory effects of these
miRNAs were mediated through specific sequences in the




Figure 3 (See legend on next page.)
Fu et al. Molecular Brain 2014, 7:71 Page 4 of 7
http://www.molecularbrain.com/content/7/1/71
(See figure on previous page.)
Figure 3 The downregulatory effects of let-7a, miR-9, and miR-129-5p are mediated via specific sequences in the human FOXP2 3′ UTR.
(A) miR-9, miR-19b, miR-140-5p, miR-200a, let-7a, miR-129-5p, miR-582-5p, and miR-892a significantly repressed luciferase activity when
co-transfected with a reporter construct containing a wild-type FOXP2 3′ UTR, but had no effects when co-transfected with a reporter construct
containing no 3′ UTR. (B) Mutations in the binding sites for let-7a, miR-9, and miR-129-5p in the human FOXP2 3′ UTR. Mutated nucleotides are
in lower case letters. (C) Mutations in both the two binding sites for let-7a, miR-9, and miR-129-5p in the FOXP2 3′ UTR abolished the repressive
effects of these miRNAs in luciferase reporter assays. Transfection was performed three times (n = 3) for each miRNA, and luciferase assays were
performed in duplicate. To control for transfection efficiency, Renilla luciferase activity was normalized to the internal control firefly luciferase
activity. Error bars = SEM; *p < 0.05, **p < 0.01, and ***p < 0.001, Tukey’s “Honest Significant Difference” test.
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cerebellum of the human fetal brain
FOXP2 is known to be expressed in several brain regions
in the human fetal brain, including the cerebellum, the
basal ganglia, the thalamus, and the cortical plate [19].
miRNAs that regulate FOXP2 expression and play a role
in brain development are expected to be expressed in
similar brain regions. We examined the expression of






Figure 4 Expression of let-7a, miR-9, and miR-129-5p in the cerebellu
signals are in red (Cy3) and DAPI stained cell nuclei are in blue. (A and B)
probe. Note the cytoplasmic localization of the let-7a signal. (C) A cerebellu
with 4 nucleotides mutated (miR-9m) detected no hybridization signal. (E)
probe. (F) A negative control probe with scrambled sequence detected no
B through F.tissue by in situ hybridization using Locked Nucleic
Acid (LNA) modified miRNA detection probes. Due to
limited tissue availability, only the cerebellum (16 weeks
old) was examined. We found that all these three miR-
NAs, let-7a, miR-9, and miR-129-5p, were expressed in
the cerebellum of the human fetal brain (Figure 4).
These observations were consistent with the roles of







m of the human fetal brain. In all images, miRNA hybridization
A cerebellum section hybridized with a LNA modified let-7a detection
m section hybridized with a miR-9 detection probe. (D) A miR-9 probe
A cerebellum section hybridized with a miR-129-5p detection
hybridization signal. The scale bars are 40 μm in A and 20 μm in
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A heterozygous missense mutation in the human FOXP2
protein coding region (i.e., R553H) results in a transcrip-
tion factor with compromised DNA binding and tran-
scriptional regulatory activity [1,20]. Presumably, reduced
functional dosage of cellular FOXP2 protein causes speech
and language impairments [12]. Our results, together with
recent reports that miR-9, miR-132, and miR-140-5p regu-
late Foxp2/FoxP2 expression (Foxp2 and FoxP2 denote re-
spective rodent and avian genes) in animal models [21,22],
highlight the importance of the FOXP2 3′ UTR sequence
and the roles for miRNAs in regulating FOXP2 expression.
These results raise the possibility that sequence variations
in the FOXP2 3′ UTR, particularly in miRNA binding
sites, due to mutations and/or polymorphism may con-
tribute to dysregulation and/or functional variations of
the FOXP2 gene. In addition, various genetic, physio-
logical, and environmental factors may influence the ex-
pression of miRNAs, thus indirectly impacting FOXP2
expression.
Human subjects carrying FOXP2 mutations exhibit
structural and functional abnormalities, presumably due
to FOXP2 malfunction, in several brain regions, includ-
ing the cerebellum [23], where FOXP2 is known to be
expressed [19]. The expression of let-7a, miR-9, and
miR-129-5p in the human fetal cerebellum is consistent
with their roles in regulating FOXP2 expression during
early cerebellum development in humans. Recently, dys-
regulation of miR-129-5p is found in the cerebellum of
autistic brains, albeit only a limited number of brains were
examined [24]. Further investigation of in vivo functions
of these miRNAs will bring insights into their roles in
speech and language development and related neural de-
velopmental disorders.
Methods
Cloning of the human FOXP2 3′ UTR and prediction of
miRNA binding sites
Human fetal brain poly(A)+RNA (Clontech) was reverse-
transcribed into cDNA using an oligo-dT primer. Using
primers designed based on the human FOXP2 3′ UTR se-
quence in the NCBI database [NCBI: NM148898, variant
II], we PCR amplified two overlapping fragments represent-
ing the FOXP2 3′ UTR. The two fragments were ligated at
a BamH1 site to obtain a 3845-nt full length human FOXP2
3′ UTR. This sequence was used for miRNA binding sites
prediction using the software TargetScan. Sequences in the
FOXP2 3′ UTR matching perfectly to the 7-nt seed se-
quence of a miRNA were accepted as putative miRNA
binding sites [16].
Transfection, Western blotting, and qRT-PCR
miRNA mimics (Ambion) were transfected into hu-
man HEK293 cells (60 nM) using Lipofectamine 2000(Invitrogen) and cells were harvested 72 hours later
for protein and mRNA assays. Proteins were separated by
electrophoresis on 10% SDS–PAGE gel. After blotting,
membranes were probed with an antibody against the hu-
man FOXP2 protein (sc-21069, Santa Cruz Biotechnol-
ogy). Protein bands were visualized using ECL-Plus and
quantified with Image J. For qRT-PCR, total RNA was
extracted from transfected cells and reverse-transcribed
(iScript cDNA synthesis kit, Bio-Rad). qRT-PCR was
performed using the SYBR Green Supermix (Bio-Rad).
Primer sequences are listed in the Additional file 1:
Figure S1. The specificity of PCR amplification products
were validated by electrophoresis and the melting-curve
analysis. For each miRNA, transfection was performed
at least three times. For each transfection, Western blot
and qRT-PCT were performed at least two times, and
qRT-PCR was performed in triplicate.
Luciferase reporter assays
Plasmid constructs carrying wild-type or mutant human
FOXP2 3′ UTRs in the psiCHECK vector (Promega,
100 ng) were co-transfected with miRNA mimics (100
nM) into SH-SY5Y cells. Cells were harvested 48 h later
and luciferase activity was assayed using the Dual-
Luciferase Reporter System (Promega). To control for
transfection efficiency, Renilla luciferase activity was
normalized to the internal control firefly luciferase activ-
ity. For each miRNA, transfection was performed three
times and luciferase activity was assayed in duplicate.
Mutagenesis of miRNA binding sites
The full length human FOXP2 3′ UTR sequence was used
as a template in site-directed mutagenesis of miRNA
binding sites using the QuikChange II XL Mutagenesis Kit
(Agilent). Specific PCR primers were designed using the
QuikChangePrimer Design tool (see Additional file 1:
Figure S1) and synthesized by Integrated Device Technol-
ogy (IDT: http://www.idt.com). In some cases, to mutate
three nucleotides in a binding site, we performed 2 rounds
of mutagenesis. For example, we mutated 2 nucleotides in
the first round, and used the mutated plasmid as a tem-
plate in the second round to mutate the third nucleotide.
All mutated binding sites were sequence verified.
In situ hybridization
In situ hybridization was performed as described previ-
ously [22]. Briefly, fixed brain sections (10 μm thick)
were hybridized with LNA modified miRNA detection
probes at 38-45°C overnight. After washing and block-
ing, slides were incubated with an Anti-Digoxigenin
antibody for 1 h, followed by signal amplification using
the TSA Plus Cy3 System (PerkinElmer). LNA modified
miRNA detection probes were purchased from Exiqon:
let-7a probe (18000–01); miR-9 probe (88078–05); a
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http://www.molecularbrain.com/content/7/1/71customer designed mutant miR-9 probe (miR-9m: 5′-
TCATAGAGCTACATAACCATACA-3′, underlined are
mutated nucleotides); miR-129-5p probe (38482–15);
negative control probe (99004–01). The human fetal brain
(16 weeks old) cerebellum sections were obtained from a
commercial source (Biochain Institute, CA).
Additional file
Additional file 1: Figure S1. Sequences of primers used in respective
experiments.
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